亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Peritoneal Dialysis Use and Practice Patterns: An International Survey Study

医学 腹膜透析 重症监护医学 内科学
作者
Yeoungjee Cho,Aminu K. Bello,Adeera Levin,Meaghan Lunney,Mohamed A. Osman,Feng Ye,Gloria Ashuntantang,Ezequiel Bellorín-Font,Mohammed Benghanem Gharbi,Sara N. Davison,Mohammad Ghnaimat,Paul Harden,Htay Htay,Vivekanand Jha,Kamyar Kalantar‐Zadeh,Peter G. Kerr,Scott Klarenbach,Csaba P. Kövesdy,Valérie A. Luyckx,Brendon L. Neuen
出处
期刊:American Journal of Kidney Diseases [Elsevier]
卷期号:77 (3): 315-325 被引量:111
标识
DOI:10.1053/j.ajkd.2020.05.032
摘要

Rationale & Objective

Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe.

Study Design

A cross-sectional survey.

Setting & Participants

Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018.

Outcomes

PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures.

Analytical Approach

Descriptive statistics.

Results

Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes.

Limitations

Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data.

Conclusions

Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lalallaal发布了新的文献求助10
刚刚
彭于晏应助伯克利芙蓉王采纳,获得10
1秒前
超级的访天完成签到,获得积分10
5秒前
6秒前
踏实凡阳完成签到,获得积分10
6秒前
7秒前
9秒前
10秒前
11秒前
lalallaal完成签到,获得积分20
12秒前
xkxkii发布了新的文献求助10
14秒前
30秒前
ding应助lalallaal采纳,获得10
35秒前
yiyimx发布了新的文献求助10
36秒前
sakuraxw发布了新的文献求助10
41秒前
42秒前
yoona发布了新的文献求助10
47秒前
NingJi应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
传奇3应助科研通管家采纳,获得10
1分钟前
1分钟前
SZH发布了新的文献求助10
1分钟前
1分钟前
英姑应助重要萍采纳,获得10
1分钟前
我是老大应助健康的雪萍采纳,获得10
1分钟前
慕青应助土豆鸡采纳,获得10
1分钟前
1分钟前
1分钟前
神勇尔蓝发布了新的文献求助20
1分钟前
重要萍发布了新的文献求助10
1分钟前
1分钟前
1分钟前
土豆鸡发布了新的文献求助10
1分钟前
小姑不在发布了新的文献求助10
2分钟前
土豆鸡完成签到,获得积分10
2分钟前
2分钟前
MyXu完成签到,获得积分10
2分钟前
小灯发布了新的文献求助10
2分钟前
田様应助执着的怜珊采纳,获得10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
T/SNFSOC 0002—2025 独居石精矿碱法冶炼工艺技术标准 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6042289
求助须知:如何正确求助?哪些是违规求助? 7790790
关于积分的说明 16237002
捐赠科研通 5188186
什么是DOI,文献DOI怎么找? 2776262
邀请新用户注册赠送积分活动 1759370
关于科研通互助平台的介绍 1642818